The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potential
Abstract
Hepatitis B virus (HBV) X protein (HBx) has been shown to be essential for the development of hepatocellular carcinoma (HCC). Recently, we have found that HBx causes the progression of liver cancer through down‐expression of PTEN, known as a tumor suppressor gene (1). The prognosis for HCC depends mainly on the clinicopathological characteristic regarding invasion and metastasis. The expression of matrix metalloproteinase (MMP)‐9 has been implicated as playing an important role in HCC invasion and metastasis. We previously reported that HBV infection increased the invasiveness of hepatocytes and HCC cells through the transcriptional activation of MMP‐9 (2). The HBx was shown to activate the mitogen‐activated protein (MAP) kinase and phosphatidylinositol 3‐kinase (PI‐3K) signal cascade, which is essential for activation of transcription factors such as activating protein (AP)‐1 and nuclear factor (NF)‐κB. In this study, we show that the HBx protein stimulates the activities of the PI‐3K‐Akt/ protein kinase B (PKB) as well as extracellular signal‐regulated kinase 1/2 (ERK 1/2) in HBx‐transfected cells. Furthermore, we have shown that enhanced expression of MMP‐9 in HBx‐transfected cells mediated by not only activation of AP‐1 transcriptional activity through ERKs pathway but also activation of NF‐κB transcriptional activity through PI‐3K‐AKT/PKB pathway, and was associated with the invasive potential. However, treatment with U0126 (known as the ERKs inhibitor) or wortmannin (known as the PI‐3K inhibitor), but not SB203580 (known as the p38 MAPK inhibitor), markedly inhibited the expression of MMP‐9 induced by HBx in HBx‐ transfected cells. Seemingly, the invasiveness of HBx‐transfected cells was decreased by treating with U0126 or wortmannin, but not SB203580. These results clearly suggest that the HBx contributed to the transcriptional regulation of MMP‐9 through the ERKs and PI‐3K‐AKT/PKB pathway, and increased an invasive potential of cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Biology and biochemistry of proteinases in tumor invasion
Mignatti, P., & Rifkin, D. B. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.1.161 · Cited by 1,244
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Self-citation92-kD type IV collagenase mediates invasion of human cytotrophoblasts.
Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, D., Galardy, R., Damsky, C. H., & Fisher, S. J. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.2.437 · Cited by 720
Matrix metalloproteinases and metastasis
Kleiner, D. E., & Stetler-Stevenson, W. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051097 · Cited by 701
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., & Harris, C. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2230 · Cited by 665
The AP-1 site and MMP gene regulation: What is all the fuss about?
Benbow, U., & Brinckerhoff, C. E. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90026-3 · Cited by 520
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Molecular insights into cancer invasion: strategies for prevention and intervention.
Kohn, E. C., & Liotta, L. A. (1995) · PubMed · Cited by 496
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
DOHOON, K., SUNHONG, K., HYONGJONG, K., SANG‐OH, Y., AN‐SIK, C., KYOUNG SANG, C., & JONGKYEONG, C. (2001) · The FASEB Journal · doi:10.1096/fj.01-0198com · Cited by 489
HBV X Protein Alters the DNA Binding Specificity of CREB and ATF-2 by Protein-Protein Interactions
Maguire, H. F., Hoeffler, J. P., & Siddiqui, A. (1991) · Science · doi:10.1126/science.1827531 · Cited by 454
MacDougall, J. R., & Matrisian, L. M. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690603 · Cited by 419
Benn, J., & Schneider, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10350 · Cited by 418
Bernhard, E. J., Gruber, S. B., & Muschel, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4293 · Cited by 385
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
Kekulé, A. S., Lauer, U., Weiss, L., Luber, B., & Hofschneider, P. H. (1993) · Nature · doi:10.1038/361742a0 · Cited by 369
Structural biochemistry and activation of matrix metalloproteases
Kleiner, D. E., & Stetler-Stevenson, W. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90040-w · Cited by 342
Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., & Tryggvason, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55326-6 · Cited by 333
Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis
Elmore, L. W., Hancock, A. R., Chang, S.-F., Wang, X. W., Chang, S., Callahan, C. P., Geller, D. A., Will, H., & Harris, C. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14707 · Cited by 333
Borden, P., & Heller, R. A. (1997) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v7.i1-2.90 · Cited by 326
Feitelson, M. A., Zhu, M., Duan, L., & London, W. T. (1993) · PubMed · Cited by 307
Benn, J., Su, F., Doria, M., & Schneider, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.4978-4985.1996 · Cited by 281
Hepatitis B Virus X Protein Interferes with Cellular DNA Repair
Becker, S. A., Lee, T.-H., Butel, J. S., & Slagle, B. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.266-272.1998 · Cited by 276
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.
Rao, J. S., Steck, P. A., Mohanam, S., Stetler‐Stevenson, W. G., Liotta, L. A., & Sawaya, R. A. (1993) · PubMed · Cited by 255
Hepatitis B virus X protein interacts with a probable cellular DNA repair protein
Lee, T. H., Elledge, S. J., & Butel, J. S. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1107-1114.1995 · Cited by 248
HBx Protein of Hepatitis B Virus Activates Jak1-STAT Signaling
Lee, Y.-H., & Yun, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25510 · Cited by 234
Self-citationGum, R., Wang, H., Lengyel, E., Juarez, J., & Boyd, D. (1997) · Oncogene · doi:10.1038/sj.onc.1200973 · Cited by 233
Arii, S., Mise, M., Harada, T., Furutani, M., Ishigami, S., Niwano, M., Mizumoto, M., Fukumoto, M., & Imamura, M. (1996) · Hepatology · doi:10.1002/hep.510240206 · Cited by 231
Activation of Src Family Kinases by Hepatitis B Virus HBx Protein and Coupled Signaling to Ras
Klein, N. P., & Schneider, R. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6427 · Cited by 231
Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling
Reddy, S. A. G., Huang, J. H., & Liao, W. S.-L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29167 · Cited by 230
Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., Goldfarb, R. H., Khoury, G., & Liotta, L. A. (1987) · PubMed · Cited by 227
Meyer, R., Hatada, E. N., Hohmann, H. P., Haiker, M., Bartsch, C., Röthlisberger, U., Lahm, H. W., Schlaeger, E. J., van Loon, A. P., & Scheidereit, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.966 · Cited by 222
Eberhardt, W., Huwiler, A., Beck, K.-F., Walpen, S., & Pfeilschifter, J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5788 · Cited by 213
Basset, P., Okada, A., Chenard, M.-P., Kannan, R., Stoll, I., Anglard, P., Bellocq, J.-P., & Rio, M.-C. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90028-7 · Cited by 208
Bernhard, E. J., Muschel, R. J., & Hughes, E. N. (1990) · PubMed · Cited by 196
X-gene Product of Hepatitis B Virus Induces Apoptosis in Liver Cells
Kim, H., Lee, H., & Yun, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.381 · Cited by 194
Shih, W.-L., Kuo, M.-L., Chuang, S.-E., Cheng, A.-L., & Doong, S.-L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003578200 · Cited by 189
Lee, Y. I., Kang-Park, S., Do, S.-I., & Lee, Y. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011263200 · Cited by 185
Self-citationWatanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., & Okada, Y. (1993) · Journal of Cell Science · doi:10.1242/jcs.104.4.991 · Cited by 182
Genersch, E., Hayeß, K., Neuenfeld, Y., & Haller, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.23.4319 · Cited by 178
Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas
Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Fuller, G. N., Stetler-Stevenson, W. G., Rao, V. H., Liotta, L. A., Nicolson, G. L., & Sawaya, R. E. (1996) · Clinical & Experimental Metastasis · doi:10.1007/bf00157681 · Cited by 169
Sato, T., Koike, L., Miyata, Y., Hirata, M., Mimaki, Y., Sashida, Y., Yano, M., & Itô, A. (2002) · PubMed · Cited by 154
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway
Chirillo, P., Falco, M., Puri, P., Artini, M., Balsano, C., Levrero, M., & Natoli, G. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.641-646.1996 · Cited by 147
Chung, T., Lee, Y., Ko, J., & Kim, C. (2003) · PubMed · Cited by 135
Self-citationHayasaka, A. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008903375 · Cited by 116
Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells
Abiru, S., Nakao, K., Ichikawa, T., Migita, K., Shigeno, M., Sakamoto, M., Ishikawa, H., Hamasaki, K., Nakata, K., & Eguchi, K. (2002) · Hepatology · doi:10.1053/jhep.2002.32676 · Cited by 111
Fini, M. E., Bartlett, J. D., Matsubara, M., Rinehart, W. B., Mody, M. K., Girard, M. T., & Rainville, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61950-2 · Cited by 109
Montgomery, A. M. P., Clerck, Y. A. D., Langley, K. E., Reisfeld, R., & Mueller, B. M. (1993) · PubMed · Cited by 104
Masure, S., Nys, G., Fiten, P., Damme, J. V., & Opdenakker, G. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18359.x · Cited by 94
Koul, D., Yao, Y., Abbruzzese, J. L., Yung, W. K. A., & Reddy, S. A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007806200 · Cited by 88
Lengyel, E. R., Gum, R. J., Juárez, J., Clayman, G. L., Seiki, M., Sato, H., & Boyd, D. D. (1995) · PubMed · Cited by 78
Hepatitis B x Protein Inhibits p53-dependent DNA Repair in Primary Mouse Hepatocytes
Prost, S., Ford, J. M., Taylor, C., Doig, J., & Harrison, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33327 · Cited by 77
Lochter, A., & Bissell, M. J. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01535.x · Cited by 74
Trans-Activation of Epidermal Growth Factor Receptor Gene by the Hepatitis B Virus X-Gene Product
Menzo, S., Clementi, M., Alfani, E., Bagnarelli, P., Iacovacci, S., Manzin, A., Dandri, M., Natoli, G., Levrero, M., & Carloni, G. (1993) · Virology · doi:10.1006/viro.1993.1550 · Cited by 74
Jiang, B., Xu, S., Brecher, P. I., & Cohen, R. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000037679.60584.3f · Cited by 43
Cited by
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis
Rowe, J., Ghouri, Y., & Mian, I. (2017) · Journal of Carcinogenesis · doi:10.4103/jcar.jcar_9_16 · Cited by 719
Steelman, L. S., Chappell, W. H., Abrams, S. L., Kempf, C. R., Long, J., Laidler, P., Mijatovic, S., Maksimovic-Ivanic, D., Stivala, F., Mazzarino, M. C., et al. (2011) · Aging · doi:10.18632/aging.100296 · Cited by 553
Chung, T., Moon, S., Chang, Y., Ko, J., Lee, Y., Cho, G., Kim, S., Kim, J., & Kim, C. (2004) · The FASEB Journal · doi:10.1096/fj.04-2126com · Cited by 456
Self-citationKindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03659-14 · Cited by 407
Metadata
- Authors
- Chung, T., Lee, Y., & Kim, C.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05-07
- Volume
- 18
- Issue
- 10
- Pages
- 1123-1125
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2038186927
- Cited by
- 288
- References
- 60
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.